Beyfortus and generic RSV immunisations are available to report to the AIR using clinical software. If these options are not visible in your medical software, first ensure the software is up-to-date and then contact your software provider if still unable to view these new additions.
Alternatively, these immunisations can be reported to the AIR via PRODA. General information about reporting of immunisations can be found on Immunisation provider information and resources.
How to record RSV immunisations in the AIR
- For all nirsevimab immunisations administered through the WA Health RSV infant immunisation program, please select Beyfortus (BFRSV).
- Only in instances where the brand administered is unknown, please select Generic RSV (GNRSV).
Note: On the AIR, when selecting a “Schedule,” please select “Other” and when selecting a “Vaccine Type”, please select “State Program” regardless of provider setting (community, hospital, GP).
Nirsevimab dosage specifications
Children aged 8 months and older (regardless of weight) will require a dosage of 200mg (2x100mg doses). When reporting to AIR, enter as a single dose. Please use only one batch number.
“Baby of” advice
For newborn babies that have not been named, use the term “Baby of (Mother’s first name)” as first name. For example, “Baby of Sally”. For multiple births, use “Baby 1 of (Mother’s first name)”, “Baby 2 of (Mother’s first name)”, etc. For surname, use mother’s surname.
For detailed instructions, refer to How to Report to the AIR via PRODA (PDF 868KB).